Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Price:
58.23
CNY
-0.87%
Market Closed
Market Cap:
¥371.4B
Relative Value
The Relative Value of one
Jiangsu Hengrui Pharmaceuticals Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 58.23 CNY,
Jiangsu Hengrui Pharmaceuticals Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Jiangsu Hengrui Pharmaceuticals Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Jiangsu Hengrui Pharmaceuticals Co Ltd Competitors
Jiangsu Hengrui Pharmaceuticals Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
386.5B CNY | 12.5 | 51.8 | 42.7 | 42.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
959.3B USD | 14.7 | 46.5 | 31.3 | 33.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.3B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.8B CHF | 4.8 | 31.1 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.2B GBP | 5.5 | 31.6 | 17.4 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.2B CHF | 5.5 | 22.2 | 13.7 | 17.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.1B USD | 4.7 | 16.7 | 10.4 | 12.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4.3 | 13 | 9.5 | 11.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.4B USD | 2.4 | 19.5 | 7.3 | 9.7 | |
| UK |
|
GSK plc
XETRA:GS71
|
103.6B EUR | 2.8 | 15.8 | 8 | 11.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
